ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic …

SAN MATEO, Calif. and SINGAPORE, Oct. 13, 2023 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused …